Arcadia Biosciences Inc (NAS:RKDA)
$ 4.24 0.19 (4.69%) Market Cap: 5.78 Mil Enterprise Value: -2.01 Mil PE Ratio: 0 PB Ratio: 0.49 GF Score: 66/100

Arcadia Biosciences Inc Annual Shareholders Meeting Transcript

Jun 01, 2020 / 08:00PM GMT
Release Date Price: $147.6 (+1.37%)
Operator

Welcome to the 2020 Annual Meeting for Arcadia Biosciences, Incorporated. Our host for today's call is Kevin Comcowich. (Operator Instructions) I would now like to turn the call over to your host. Kevin, you may begin.

Kevin J. Comcowich
Arcadia Biosciences, Inc. - Independent Chairman of the Board

Good morning, ladies and gentlemen. I'm Kevin Comcowich, Chairman of the Board of Directors of Arcadia Biosciences, and it's my pleasure to welcome you to the Arcadia Biosciences' Annual Meeting of Stockholders. I will act as Chair of this meeting, and I've got Pam Haley, our Chief Financial Officer and Corporate Secretary to record the minutes of this meeting.

Before proceeding further, let me introduce the Directors and Director nominees of the company who are on the call with us today: Albert Bolles, Director; Matt Plavan, Director, who is also our President and Chief Executive Officer of Arcadia; Lilian Shackelford Murray, Director; Greg Waller, Director and Nominee; and Amy Yoder, Director.

I would also like to introduce the corporate

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot